spacer
home > pmps > winter 2003 > the ultimate solution for reducing medication errors
PUBLICATIONS
Pharmaceutical Manufacturing and Packing Sourcer

The Ultimate Solution for Reducing Medication Errors

Are the right patients receiving the right drugs in the right dosage at the right time? Preventing medication errors is high on the agenda not only of hospitals, but the pharmaceutical wholesalers, the pharmaceutical industry and also governments worldwide. The American health care sector is focusing on minimising errors in administering medication. By scanning medication at the patient's bedside, errors can be reduced by as much as 50 per cent or more according to the Federal Drug Administration (FDA). It is no wonder therefore that in mid-2003, the FDA ruled that there should be bar codes on each unit dose. Much research is carried out in order to calculate the percentage of medication errors occurring. Just about every country worldwide has done at least one research project on this subject.

Depending on which research report you read (and depending on the definition of medication error used) the percentage of medication errors varies between 10 and 25 per cent. Almost 0.5 per cent result in permanent injury and 0.25 per cent of patients die due to the wrong medicine or wrong dosage being administered. Although it looks like a small percentage in relation to the size of the population, this number is unacceptable. In addition, the costs of recovery, such as the expense of contra-medication and an extra stay in hospital, are estimated to be an annual 300 million in countries such as The Netherlands. These figures are worrying, especially if you have ever been a patient, and solutions must be found.


Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

spacer
By Eric Tjoa, CEO at Tjoapack BV

Eric Tjoa founded TjoaPack, a pharmaceutical contract packaging company, in 1989. He holds a Masters in Pharmacy and has given several national and international presentations concerning bar coding and standardisation of unit dose packages, amongst other subjects, at the University of the Western Cape, the EAN conferences in 2002 and 2003, and at the EAHP 1999 in Nice.

spacer
Eric Tjoa
spacer
spacer
Print this page
Send to a friend
Privacy statement
News and Press Releases

Conversis Medical Appoints Dr Mark Hooper

Conversis Medical, the specialist medical translation agency, has announced the appointment of Dr Mark Hooper as Global Director. With extensive business development and project delivery experience in the pharmaceutical and CRO/CMO market, Mark brings in-depth understanding of the scientific, regulatory and time-pressured nature of projects in drug development and clinical trials.
More info >>

White Papers

The current and future role of the medical oncologist in the professional care for cancer patients: a position paper by the European Society for Medical Oncology

European Society for Medical Oncology (ESMO)

  The number of cancer patients in Europe is rising and significant advances in basic and applied cancer research are making the provision of optimal care more challenging. The concept of cancer as a systemic, highly heterogeneous and complex disease has increased the awareness that quality cancer care should be provided by a multidisciplinary team (MDT) of highly qualified healthcare professionals. Cancer patients also have the right to benefit from medical progress by receiving optimal treatment from adequately trained and highly skilled medical professionals. Built on the highest standards of professional training and continuing medical education, medical oncology is recognised as an independent medical specialty in many European countries.
More info >>

 
Industry Events

Analytical Method Development, Validation and Transfer

9-10 September 2014, Maritim proArte Hotel, Berlin, Germany

Informa life Sciences Analytical Method Development, Transfer and Validation is a dedicated forum focusing solely on new method development, validation and transfer for pharmaceutical and generics manufacturers.
More info >>

 

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement